Fellowship · Houston, TX
Sponsored by Baylor College of Medicine
Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee.
Journal of clinical immunology · 2022 · 929 citations · Jennifer Puck
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.
The New England journal of medicine · 2021 · 1,180 citations · Robert Frenck
Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.
American journal of respiratory and critical care medicine · 2025 · 112 citations · Jeffrey Starke
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.
The New England journal of medicine · 2021 · 698 citations · Robert Frenck
Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024.
MMWR. Morbidity and mortality weekly report · 2024 · 183 citations · Pedro Piedra
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study.
BMJ (Clinical research ed.) · 2022 · 544 citations ·
The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of Immunity.
Journal of clinical immunology · 2022 · 407 citations · Jennifer Puck
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.
The New England journal of medicine · 2022 · 477 citations · Robert Frenck